Detection of lymphatic micrometastases in patients with Stages I and II colorectal cancer: Impact on five-year survival

Diseases of the Colon and Rectum

Volumn 47, Issue 7, 2004, Pages 1151-1157

  Kronberg, Udo ^a   López Kostner, Francisco ^a,b   Soto, Gonzalo ^a   Zúñiga A , Alvaro ^a   Wistuba, Ignacio ^a   Miranda, Vanessa ^a   Pinto, Eliana ^a   Viviani, Paola ^a   Marshall, Guillermo ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b Department of Digestive Surgery ^*  (Chile)

Author keywords

Cancer specific survival; Colorectal cancer; Follow up; Immunohistochemistry; Lymphatic micrometastases

Indexed keywords

ANTIBODY; CYTOKERATIN;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; CANCER MORTALITY; CANCER RECURRENCE; CANCER RELATED DEATH; CANCER SPECIFIC SURVIVAL; CANCER SURGERY; CANCER SURVIVAL; COLORECTAL CANCER; COLORECTAL CANCER STAGE I; COLORECTAL CANCER STAGE II; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LOG RANK TEST; LYMPH NODE METASTASIS; LYMPHATIC MICROMETASTASIS; MAJOR CLINICAL STUDY; MALE;

EID: 3042745084     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10350-004-0560-9     Document Type: Article

References (28)

1. Phillips RK, Hittinger R, Blesovsky L, Fry JS, Fielding LP. Large bowel cancer: surgical pathology and its relationship to survival. Br J Surg 1984;71:604-10.
2. Fielding LP, Phillips RK, Fry JS, Hittinger R. Prediction of outcome after curative resection for large bowel cancer. Lancet 1986;2:904-7.
3. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators. Lancet 1995;345:939-44.
4. Cutait R, Alves VA, Lopes LC, et al. Restaging of colorectal cancer based on the identification of lymph node micrometastases through immunoperoxidase staining of CEA and cytokeratins. Dis Colon Rectum 1991;34: 917-20.
5. Haboubi NY, Clark P, Kaftan SM, Schofield PF. The importance of combining xylene clearance and immunohistochemistry in the accurate staging of colorectal carcinoma. J R Soc Med 1992;85:386-8.
6. Jeffers MD, O'Dowd GM, Mulcahy H, Stagg M, O'Donoghue DP, Toner M. The prognostic significance of immunohistochemically detected lymph node micrometastases in colorectal carcinoma. J Pathol 1994;172: 183-7.
7. Greenson JK, Isenhart CE, Rice R, Mojzisik C, Houchens D, Martin EW. Identification of occult micrometastases in pericolic lymph nodes of Dukes B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Correlation with long-term survival. Cancer 1994;73:563-9.
8. Cote RJ, Houchens DP, Hitchcock CL, et al. Intraoperative detection of occult colon cancer micrometastases using 125 I-radiolabeled monoclonal antibody CC49. Cancer 1996;77:613-20.
9. Adell G, Boeryd B, Franlund B, Sjodahl R, Hakansson L. Occurrence and prognostic importance of micrometastases in regional lymph nodes in Dukes' B colorectal carcinoma: an immunohistochemical study. Eur J Surg 1996;162:637-42.
10. Broll R, Schauer V, Schimmelpenning H, et al. Prognostic relevance of occult tumor cells in lymph nodes of colorectal carcinomas: an immunohistochemical study. Dis Colon Rectum 1997;40:1465-71.
11. Sasaki M, Watanabe H, Jass JR, et al. Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in "node-negative" colorectal cancer. J Gastroenterol 1997;32:758-64.
12. Oberg A, Stenling R, Tavelin B, Lindmark G. Are lymph node micrometastases of any clinical significance in Dukes Stages A and B colorectal cancer? Dis Colon Rectum 1998;41:1244-9.
13. Hitchcock CL, Sampsel J, Young DC, Martin EW, Arnold MW. Limitations with light microscopy in the detection of colorectal cancer cells. Dis Colon Rectum 1999;42: 1046-52.
14. Isaka N, Nozue M, Doy M, Fukao K. Prognostic significance of perirectal lymph node micrometastases in Dukes' B rectal carcinoma: an immunohistochemical study by CAM5.2. Clin Cancer Res 1999;5:2065-8.
15. Makin CA, Bobrow LG, Nicholls RJ. Can immunohistology improve detection of lymph-node metastases in large- bowel cancer? Dis Colon Rectum 1989;32:99-102.
16. Cote RJ, Peterson HF, Chaiwun B, et al. Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. International Breast Cancer Study Group. Lancet 1999;354:896-900.
17. Turner RR, Ollila DW, Stern S, Giuliano AE. Optimal histopathologic examination of the sentinel lymph node for breast carcinoma staging. Am J Surg Pathol 1999;23:263-7.
18. Yared MA, Middleton LP, Smith TL, et al. Recommendations for sentinel lymph node processing in breast cancer. Am J Surg Pathol 2002;26:377-82.
19. Liefers GJ, Cleton-Jansen AM, van-de Velde CJ, et al. Micrometastases and survival in stage II colorectal cancer. N Engl J Med 1998;339:223-8.
20. Izbicki JR, Hosch SB. Minimal dissemination of solid epithelial tumours: impact on staging and therapeutic strategy. Br J Surg 1997;84:897-8.
21. Kell MR, Winter DC, O'Sullivan GC, Shanahan F, Redmond HP. Biological behaviour and clinical implications of micrometastases. Br J Surg 2000;87:1629-39.
22. Hosch SB, Braun S, Pantel K. Characterization of disseminated tumor cells. Semin Surg Oncol 2001;20:265-71.
23. Pantel K, Cote RJ, Fodstad O. Detection and clinical importance of micrometastastic disease. J Natl Cancer Inst 1999;91:1113-24.
24. Demicheli R, Terenziani M, Valagussa P, Moliterni A, Zambetti M, Bonadonna G. Local recurrences following mastectomy: support for the concept of tumor dormancy. J Natl Cancer Inst 1994;86:45-8.
25. McDonnell CO, Hill ADK, McNamara DA, Walsh TN, Bouchier-Hayes DJ. Tumour micrometastases: the influence of angiogenesis. Eur J Surg Oncol 2000;26: 105-15.
26. Laheru DA, Jaffee EM. Potential role of tumor vaccines in GI malignancies. Oncology 2000;14:245-56.
27. Shu S, Plautz GE, Krauss JC, Chang AE. Tumor immunology. J Am Med Assoc 1997;278:1972-81.
28. Boura P, Kountouras J, Lygidakis NJ. Tumor immunity and immunotherapy. Hepatogastroenterology 2001;48: 1040-4.